Clinical trial
A Dual-Perspective, Multi-Method Integrated Pharmacoeconomic Evaluation of Yiqi Fumai Lyophilized Injection for NYHA Class II or III Chronic Left Ventricular Dysfunction Due to Coronary Heart Disease in Patients With Qi and Yin Deficiency Syndrome: A Multicenter, Prospective, Open-Label, Single-Arm Performance-Goal Study
NCT07803471 is registered in ClinicalTrials.gov with China Academy of Chinese Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Dual-Perspective, Multi-Method Integrated Pharmacoeconomic Evaluation of Yiqi Fumai Lyophilized Injection for NYHA Class II or III Chronic Left Ventricular Dysfunction Due to Coronary Heart Disease in Patients With Qi and Yin Deficiency Syndrome: A Multicenter, Prospective, Open-Label, Single-Arm Performance-Goal Study
- Lead sponsor
- China Academy of Chinese Medical Sciences
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- October 31, 2027
- Enrollment
- 100 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
chronic heart failure, coronary heart disease (chd), heart failure with reduced ejection fraction (hfref)